HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus

Edward R. Sauter, Steven M. Keller, Susan Erner, Melvyn Goldberg

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Adenocarcinoma of the esophagus is an aggressive malignancy which is increasing in frequency. The HER-2/neu oncogene product is a putative differentiation marker which exhibits decreased expression in colon carcinoma, while there is overexpression in breast and ovarian cancers. We analyzed the relationship of cell differentiation to HER-2/neu expression in esophageal adenocarcinoma using immunohistochemistry on formalin-fixed, paraffin-embedded material from 14 patients whose tissue contained normal, dysplastic, and malignant features. HER-2/neu expression was detected in 1 of 14 biopsy specimens and 2 of 9 resection specimens. The oncoprotein staining was greatest in normal tissue, less in dysplastic tissue, and not detected in malignant tissue. Our findings, similar to what is seen in the colon, suggest that the HER-2/neu oncogene product is a differentiation marker which is lost in esophageal adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)41-44
Number of pages4
JournalCancer Letters
Volume75
Issue number1
DOIs
StatePublished - Nov 30 1993
Externally publishedYes

Fingerprint

Differentiation Antigens
Oncogene Proteins
Colon
Adenocarcinoma
Paraffin
Ovarian Neoplasms
Formaldehyde
Cell Differentiation
Immunohistochemistry
Staining and Labeling
Breast Neoplasms
Carcinoma
Biopsy
Adenocarcinoma Of Esophagus
Neoplasms

Keywords

  • Differentiation marker
  • Esophageal adenocarcinoma
  • HER-2/neu

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

HER-2/neu : a differentiation marker in adenocarcinoma of the esophagus. / Sauter, Edward R.; Keller, Steven M.; Erner, Susan; Goldberg, Melvyn.

In: Cancer Letters, Vol. 75, No. 1, 30.11.1993, p. 41-44.

Research output: Contribution to journalArticle

Sauter, ER, Keller, SM, Erner, S & Goldberg, M 1993, 'HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus', Cancer Letters, vol. 75, no. 1, pp. 41-44. https://doi.org/10.1016/0304-3835(93)90205-N
Sauter, Edward R. ; Keller, Steven M. ; Erner, Susan ; Goldberg, Melvyn. / HER-2/neu : a differentiation marker in adenocarcinoma of the esophagus. In: Cancer Letters. 1993 ; Vol. 75, No. 1. pp. 41-44.
@article{5625f98021b849ca86999b1faa3f1b81,
title = "HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus",
abstract = "Adenocarcinoma of the esophagus is an aggressive malignancy which is increasing in frequency. The HER-2/neu oncogene product is a putative differentiation marker which exhibits decreased expression in colon carcinoma, while there is overexpression in breast and ovarian cancers. We analyzed the relationship of cell differentiation to HER-2/neu expression in esophageal adenocarcinoma using immunohistochemistry on formalin-fixed, paraffin-embedded material from 14 patients whose tissue contained normal, dysplastic, and malignant features. HER-2/neu expression was detected in 1 of 14 biopsy specimens and 2 of 9 resection specimens. The oncoprotein staining was greatest in normal tissue, less in dysplastic tissue, and not detected in malignant tissue. Our findings, similar to what is seen in the colon, suggest that the HER-2/neu oncogene product is a differentiation marker which is lost in esophageal adenocarcinoma.",
keywords = "Differentiation marker, Esophageal adenocarcinoma, HER-2/neu",
author = "Sauter, {Edward R.} and Keller, {Steven M.} and Susan Erner and Melvyn Goldberg",
year = "1993",
month = "11",
day = "30",
doi = "10.1016/0304-3835(93)90205-N",
language = "English (US)",
volume = "75",
pages = "41--44",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - HER-2/neu

T2 - a differentiation marker in adenocarcinoma of the esophagus

AU - Sauter, Edward R.

AU - Keller, Steven M.

AU - Erner, Susan

AU - Goldberg, Melvyn

PY - 1993/11/30

Y1 - 1993/11/30

N2 - Adenocarcinoma of the esophagus is an aggressive malignancy which is increasing in frequency. The HER-2/neu oncogene product is a putative differentiation marker which exhibits decreased expression in colon carcinoma, while there is overexpression in breast and ovarian cancers. We analyzed the relationship of cell differentiation to HER-2/neu expression in esophageal adenocarcinoma using immunohistochemistry on formalin-fixed, paraffin-embedded material from 14 patients whose tissue contained normal, dysplastic, and malignant features. HER-2/neu expression was detected in 1 of 14 biopsy specimens and 2 of 9 resection specimens. The oncoprotein staining was greatest in normal tissue, less in dysplastic tissue, and not detected in malignant tissue. Our findings, similar to what is seen in the colon, suggest that the HER-2/neu oncogene product is a differentiation marker which is lost in esophageal adenocarcinoma.

AB - Adenocarcinoma of the esophagus is an aggressive malignancy which is increasing in frequency. The HER-2/neu oncogene product is a putative differentiation marker which exhibits decreased expression in colon carcinoma, while there is overexpression in breast and ovarian cancers. We analyzed the relationship of cell differentiation to HER-2/neu expression in esophageal adenocarcinoma using immunohistochemistry on formalin-fixed, paraffin-embedded material from 14 patients whose tissue contained normal, dysplastic, and malignant features. HER-2/neu expression was detected in 1 of 14 biopsy specimens and 2 of 9 resection specimens. The oncoprotein staining was greatest in normal tissue, less in dysplastic tissue, and not detected in malignant tissue. Our findings, similar to what is seen in the colon, suggest that the HER-2/neu oncogene product is a differentiation marker which is lost in esophageal adenocarcinoma.

KW - Differentiation marker

KW - Esophageal adenocarcinoma

KW - HER-2/neu

UR - http://www.scopus.com/inward/record.url?scp=0027762554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027762554&partnerID=8YFLogxK

U2 - 10.1016/0304-3835(93)90205-N

DO - 10.1016/0304-3835(93)90205-N

M3 - Article

C2 - 7904538

AN - SCOPUS:0027762554

VL - 75

SP - 41

EP - 44

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -